Literature DB >> 16645050

Emergent properties of reduced-genome Escherichia coli.

György Pósfai1, Guy Plunkett, Tamás Fehér, David Frisch, Günther M Keil, Kinga Umenhoffer, Vitaliy Kolisnychenko, Buffy Stahl, Shamik S Sharma, Monika de Arruda, Valerie Burland, Sarah W Harcum, Frederick R Blattner.   

Abstract

With the use of synthetic biology, we reduced the Escherichia coli K-12 genome by making planned, precise deletions. The multiple-deletion series (MDS) strains, with genome reductions up to 15%, were designed by identifying nonessential genes and sequences for elimination, including recombinogenic or mobile DNA and cryptic virulence genes, while preserving good growth profiles and protein production. Genome reduction also led to unanticipated beneficial properties: high electroporation efficiency and accurate propagation of recombinant genes and plasmids that were unstable in other strains. Eradication of stress-induced transposition evidently stabilized the MDS genomes and provided some of the new properties.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16645050     DOI: 10.1126/science.1126439

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  250 in total

1.  Analysis of the functions of recombination-related genes in the generation of large chromosomal deletions by loop-out recombination in Aspergillus oryzae.

Authors:  Tadashi Takahashi; Masahiro Ogawa; Yasuji Koyama
Journal:  Eukaryot Cell       Date:  2012-01-27

2.  Lambda red recombineering in Escherichia coli occurs through a fully single-stranded intermediate.

Authors:  J A Mosberg; M J Lajoie; G M Church
Journal:  Genetics       Date:  2010-09-02       Impact factor: 4.562

3.  Structural and operational complexity of the Geobacter sulfurreducens genome.

Authors:  Yu Qiu; Byung-Kwan Cho; Young Seoub Park; Derek Lovley; Bernhard Ø Palsson; Karsten Zengler
Journal:  Genome Res       Date:  2010-06-30       Impact factor: 9.043

4.  Transcription termination maintains chromosome integrity.

Authors:  Robert S Washburn; Max E Gottesman
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-23       Impact factor: 11.205

Review 5.  Exploiting plug-and-play synthetic biology for drug discovery and production in microorganisms.

Authors:  Marnix H Medema; Rainer Breitling; Roel Bovenberg; Eriko Takano
Journal:  Nat Rev Microbiol       Date:  2010-12-29       Impact factor: 60.633

Review 6.  How to make a minimal genome for synthetic minimal cell.

Authors:  Liu-Yan Zhang; Su-Hua Chang; Jing Wang
Journal:  Protein Cell       Date:  2010-06-04       Impact factor: 14.870

Review 7.  Engineering of a genome-reduced host: practical application of synthetic biology in the overproduction of desired secondary metabolites.

Authors:  Hong Gao; Ying Zhuo; Elizabeth Ashforth; Lixin Zhang
Journal:  Protein Cell       Date:  2010-07-29       Impact factor: 14.870

Review 8.  Current state and recent advances in biopharmaceutical production in Escherichia coli, yeasts and mammalian cells.

Authors:  Aleš Berlec; Borut Strukelj
Journal:  J Ind Microbiol Biotechnol       Date:  2013-02-06       Impact factor: 3.346

Review 9.  Plasmid DNA vaccine vector design: impact on efficacy, safety and upstream production.

Authors:  James A Williams; Aaron E Carnes; Clague P Hodgson
Journal:  Biotechnol Adv       Date:  2009-02-20       Impact factor: 14.227

Review 10.  Engineering reduced evolutionary potential for synthetic biology.

Authors:  Brian A Renda; Michael J Hammerling; Jeffrey E Barrick
Journal:  Mol Biosyst       Date:  2014-02-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.